StocksA › APOG

Apogee Enterprises, Inc. (APOG) — Earnings Call X-Ray

Our AI read all 39 of APOG's earnings calls (2015–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q1 2026 · sign up to see
Previous Call Grade
C
Q4 2025
Expected Move
🔒
next 45 days · members
Calls Analyzed
39
2015–2025
Avg Candor
7.5/9
evasion 2.2/9
Guidance LoweredHigh CandorCritic AmmunitionUnderused Fixed CostsRaising PricesMargins ContractingDemand SlowingCutting Headcount

Call-by-call analysis

🔒 Q1 2026 earnings call 2025-06-27 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q1 2026 call grade is ready
The full 37-point AI read of APOG's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

C Q4 2025 earnings call 2025-04-24 move ±11.7%

Management lowered guidance against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: slowingMargins: contractingBacklog: shrinkingPricing: raisingHeadcount: cuttingCapex: flat 3 analysts · 7 questions
⚑ Critic ammunition✓ Guidance underwritable✓ Resolves doubtsHidden segmentDirection beats results
Candor 8/9
Specificity 8/9
Evasion 2/9
Confidence 6/9
Uncertainty 6/9
Promotion 4/9
Stress 4/9
Complexity 5/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
YES Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C Q3 2025 earnings call 2025-01-07 move ±18.7%

Management lowered guidance against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: slowingMargins: contractingBacklog: shrinkingPricing: under pressureCapex: flat 4 analysts · 11 questions
⚑ Critic ammunition✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsedCFO dominates
Candor 8/9
Specificity 8/9
Evasion 2/9
Confidence 6/9
Uncertainty 5/9
Promotion 4/9
Stress 3/9
Complexity 4/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

B+ Q2 2025 earnings call 2024-10-04 move ±17.7%

Management raised guidance against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics, relaxed under questioning.

Guidance: raisedDemand: mixedMargins: expandingBacklog: shrinkingPricing: under pressureCapex: flat 4 analysts · 16 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsDirection beats results
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 5/9
Promotion 6/9
Stress 1/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B+ Q1 2025 earnings call 2024-06-27 move ±9.6%

Management raised guidance against slowing demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: raisedDemand: slowingMargins: expandingBacklog: growingPricing: under pressureCapex: flat 4 analysts · 10 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts
Candor 8/9
Specificity 7/9
Evasion 2/9
Confidence 7/9
Uncertainty 5/9
Promotion 4/9
Stress 2/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q4 2024 earnings call 2024-04-18 move ±10.4%

Management lowered guidance against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: mixedMargins: expandingBacklog: growingPricing: under pressureCapex: flat 4 analysts · 8 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsDirection beats results
Candor 8/9
Specificity 9/9
Evasion 2/9
Confidence 7/9
Uncertainty 5/9
Promotion 4/9
Stress 2/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B+ Q3 2024 earnings call 2023-12-21 move ±8.3%

Management raised guidance against slowing demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: raisedDemand: slowingMargins: expandingBacklog: growingPricing: raisingCapex: decreasing 3 analysts · 8 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsedCFO dominates
Candor 7/9
Specificity 7/9
Evasion 2/9
Confidence 8/9
Uncertainty 5/9
Promotion 4/9
Stress 2/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

B+ Q2 2024 earnings call 2023-09-19 move ±8%

Management raised guidance against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics, relaxed under questioning.

Guidance: raisedDemand: mixedMargins: expandingBacklog: shrinkingPricing: raisingCapex: increasing 3 analysts · 8 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsedCFO dominates
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 4/9
Promotion 5/9
Stress 1/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q1 2024 2023-06-23 B+ raisedmixedexpanding 8/9 2/9
Q4 2023 2023-04-12 B maintainedmixedexpanding 7/9 2/9
Q3 2023 2022-12-22 B maintainedstableexpanding 7/9 2/9
Q2 2023 2022-09-20 A raisedstableexpanding 7/9 2/9
Q1 2023 2022-06-23 B+ raisedstableexpanding 7/9 2/9
Q4 2022 2022-04-07 B maintainedmixedexpanding 7/9 2/9
Q3 2022 2021-12-21 B+ raisedstableexpanding 8/9 2/9
Q2 2022 2021-09-21 C maintainedmixedcontracting 7/9 4/9
Q1 2022 2021-06-25 B raisedmixedexpanding 7/9 4/9
Q4 2021 2021-04-08 C noneslowingexpanding 7/9 2/9
Q3 2021 2020-12-18 C withdrawnslowingexpanding 8/9 2/9
Q2 2021 2020-09-17 C+ withdrawnmixedexpanding 8/9 1/9
Q1 2021 2020-06-26 C withdrawnmixedcontracting 8/9 2/9
Q4 2020 2020-04-02 C withdrawnmixedcontracting 7/9 2/9
Q3 2020 2019-12-19 D loweredmixedcontracting 8/9 2/9
Q2 2020 2019-09-17 C+ maintainedstablecontracting 7/9 3/9
Q1 2020 2019-06-27 B maintainedstablestable 7/9 5/9
Q4 2019 2019-04-11 B raisedacceleratingcontracting 7/9 4/9
Q3 2019 2018-12-20 D loweredmixedcontracting 7/9 3/9
Q2 2019 2018-09-18 C loweredacceleratingcontracting 8/9 2/9
Q1 2019 2018-06-28 A raisedacceleratingexpanding 8/9 1/9
Q4 2018 2018-04-12 D loweredstablecontracting 8/9 2/9
Q3 2018 2017-12-21 C loweredstablecontracting 7/9 3/9
Q2 2018 2017-09-19 B maintainedmixedcontracting 7/9 1/9
Q1 2018 2017-06-22 C+ maintainedacceleratingcontracting 8/9 2/9
Q4 2017 2017-04-13 B+ maintainedacceleratingexpanding 8/9 1/9
Q3 2017 2016-12-15 B+ raisedacceleratingexpanding 7/9 2/9
Q2 2017 2016-09-15 B+ raisedacceleratingexpanding 8/9 2/9
Q1 2017 2016-06-23 B+ raisedstableexpanding 7/9 2/9
Q4 2016 2016-04-07 B+ maintainedacceleratingexpanding 8/9 2/9
Q3 2016 2015-12-17 B+ raisedmixedexpanding 8/9 2/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of APOG's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

A Q2 2023 earnings call 2022-09-20

B+ Q1 2023 earnings call 2022-06-23

1 more research questions answered NO

C Q2 2019 earnings call 2018-09-18

1 more research questions answered NO

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAP · Advance Auto Parts, Inc.ABCAF · Athabasca Minerals, Inc.ABDC · Alcentra Capital'sABMD · Abiomed, Inc.ABNRY · ABN AMRO Bank N.V.ABOS · Acumen Pharmaceuticals,

APO   All “A” companies    APOL

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.